page_head_bg

products

Tofacitinib intermedia (3R, 4R) -1-benzyl-3- (methylamino) -4-methylpiperidine dihydrochloride;Cis 1-benzyl-4-methyl-3-methylamino piperidine dihydrochloride CAS No.

Description:

Formulae hypotheticae:C14H24Cl2N2
Pondus hypotheticum:291.260


Product Detail

Product Tags

Descriptio

Medium nostrum tofacitinib, etiam notum est ut cis-1-benzyl-4-methyl-3-methylaminopiperidinem dihydrochloridem et numerum 1062580-52-2 habet.Medium medicamentum clavis est in productione tofacitinib, medicamentum ad arthritis rheumatoidem tractandum, arthritis psoriaticum et ulcerativum colitis.Sicut intermedia clavis in synthesi tofacitinib, fructus nostri vitales sunt ad inquisitores pharmaceuticos et artifices.

Compositio haec intermedia accurate summa ratione perstringitur ut in summa integritate et constantia curet.Cum nostro statu-of-arte processuum fabricandi et mensurarum qualitatem restrictam, confidere potes ut intermedia nostra tofacitinib conveniant summae industriae signa ad puritatem et stabilitatem.

Tofacitinib Intermedia (3R, 4R) -1-Benzyl-3- (Mmethylamino) -4-Mmethylpiperidine DiHClide amplis applicationes habet, eamque in investigationibus pharmaceuticis et chemicis magni ponderis facit.Utrum investigationem academicam agas vel pharmaceutica elaborandum, compositiones intermediae nostrae solutiones certas et sumptus efficaces tuis certis necessitatibus praebent.

Elige Us

JDK facilities productio primae classis et armorum administratio Qualitas habet, quod stabilitatem API intermediis confirmat.Professional team assure R&D producti.Contra utrumque, CMO & CDMO in foro domestico et internationali quaerimus.


  • Priora:
  • Deinde: